Symbol
MBX on Nasdaq
Investment type
Equity / COMMON STOCK
Latest Disclosed Shares Owned
2,017,394 shares
Security Ownership %
4.5%

Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. ownership in MBX Biosciences, Inc. COMMON STOCK (MBX)

12 Nov 2025 - Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,017,394 shares of MBX Biosciences, Inc. COMMON STOCK (MBX). This represents 4.5% ownership of the company. This is the first filing by Wellington Biomedical Innovation Master Investors (Cayman) II L.P. disclosing ownership of MBX Biosciences, Inc. COMMON STOCK (MBX).